Role of injectable and oral polio vaccines in polio eradication

Expert Review of Vaccines

Volumn 8, Issue 1, 2009, Pages 5-8

  John, Jacob ^a,b  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; EDITORIAL; HEALTH PROGRAM; HERD IMMUNITY; HUMAN; INFECTION CONTROL; POLIOMYELITIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SEROCONVERSION; VIRUS TRANSMISSION;

HUMANS; POLIOMYELITIS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL;

EID: 58149386022     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.8.1.5     Document Type: Editorial

References (26)

1. World Health Organization. Primary Health Care. A Joint Report by the Director General of the World Health Organization and the Executive Director of the United Nations Children's Fund, New York. World Health Organization, Geneva, Switzerland (1978).
2. Walsh JA, Warren KS. Selective Primary Health Care: an interim strategy for disease control in developing countries. N. Engl. J. Med. 301, 967-974 (1979).
3. World Health Assembly. Global Eradication of Poliomyelitis by the Year 2000. Resolution WHA 41.28, 41st World Health Assembly, 2-13 May 1988. Resolutions and Decisions Annexes. World Health Organization, Geneva, Switzerland (1988).
4. Hull HF, Ward NA, Milstein JB, de Quadros CA. Paralytic poliomyelitis, seasoned startegies, disappearing disease. Lancet 343, 1331-1337 (1994).
5. Malvy DJ, Drucker J. Elimination of poliomyelitis in France: epidemiology and vaccine status. Public Health Rev. 21, 41-49 (1993).
6. Centers for Disease Control and Prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices. Poliomyelitis prevention in the United States. MMWR Morb. Mortal. Wkly Rep. 49(RR-5), 1-22 (2000).
7. John TJ. Can we eradicate poliomyelitis? In: Frontiers in Pediatrics. Sachdev HPS, Choudhury P (Eds). Jaypee Bros., New Delhi, India 76-90 (1996).
8. John TJ. Will India need inactivated poliovirus vaccine (IPV) to complete polio eradication? Indian J. Med. Res. 122, 365-367 (2005).
9. Lapinleimu K. Elimination of poliomyelitis in Finland. Rev. Infect. Dis. 6(Suppl. 2), S457-S460 (1984).
10. Bottiger M. The elimination of polio in the Scandinavian countries. Public Health Rev. 21, 27-33 (1993).
11. John TJ. Problems with oral poliovaccine in India. Indian Pediatr. 9, 252-256 (1972).
12. John TJ. Immunisation againt polioviruses in developing countries. Rev. Med. Virol. 3, 149-160 (1993).
13. John TJ. Polar spectrum of problems in polio eradication. Indian J. Med. Res. 120, 13-135 (2004).
14. Grassly NC, Fraser C, Wenger J et al. New strategies for the elimination of polio from India. Science 314, 1150-1153 (2006).
15. Polio Eradication Committee, Indian Academy of Pediatrics. Universal immunisation programme and polio eradication in India. Indian Pediatr. 45, 807-813 (2008).
16. World Health Organization Consultative Group. The relation between acute persisting spinal paralysis and poliomyelitis vaccine. Results of a ten-year enquiry. Bull. World Health Organ. 60, 231-242 (1982).
17. Kew OM, Sutter RW, de Gourville EM et al. Vaccine-derived poloviruses and endgame strategy for global polio eradication. Ann. Rev. Microbiol. 59, 587-635 (2005).
18. Huang QS, Greening G, Baker MG et al. Persistence of oral polio vaccine virus after its removal from the immunization schedule in New Zealand. Lancet 366, 394-396 (2005).
19. Robertson SE, Drucker JA, Rovira EZ et al. Clinical efficacy of a new enhanced potency inactivated poliovirus vaccine. Lancet 1(8591), 897-899 (1988).
20. John TJ. Anomalous observations on IPV and OPV vaccination. Dev. Biol. (Basel) 105, 197-208 (2001).
21. John TJ. The golden jubilee of vaccination against poliomyelitis. Indian J. Med. Res. 119, 1-17 (2004).
22. Krishnan R, Jadhav M, John TJ. Efficacy of inactivated polio vaccine in India. Bull. World Health Organ. 61, 689-692 (1983).
23. Simoes EAF, Padmini B, Steinhoff MC et al. Antibody response of infants to two doses of inactivated poliovirus vaccine of enhanced potency. Am. J. Dis. Child. 139, 977-970 (1985).
24. John TJ. Establish herd effect to interrupt wild poliovirus transmission. Indian J. Med. Res. 124, 1-4 (2006).
25. Faden H, Modlin JF, Thomas ML et al. Comparative evaluation with live attenuated and enhanced potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J. Infect. Dis. 162, 1291-1297 (1990).
26. Paul Y. Oral polio vaccines and their role in polio eradication in India. Expert Rev. Vaccines 8(1), 35-41 (2009).